A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 2 Arm Study to Investigate the Safety of a 4-dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
Latest Information Update: 13 Jun 2025
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary) ; Hepatitis A vaccine inactivated (Primary) ; Hepatitis A vaccine inactivated (Primary) ; Hepatitis A vaccine inactivated (Primary) ; Hib-DTaP-hepatitis B-poliovirus vaccine (Primary) ; Hib-DTaP-hepatitis B-poliovirus vaccine (Primary) ; Measles mumps and rubella virus vaccine (Primary) ; Measles mumps and rubella virus vaccine (Primary) ; Measles mumps and rubella virus vaccine-(Priorix) (Primary) ; RIX 4414 (Primary) ; Rotavirus W179-9 vaccine (Primary) ; SP-0202 (Primary) ; Varicella zoster virus vaccine live (Primary) ; Varicella zoster virus vaccine live (Primary)
- Indications Pneumococcal infections
- Focus Adverse reactions; Registrational
- Sponsors Sanofi
Most Recent Events
- 21 Feb 2025 New trial record
- 20 Feb 2025 Status changed from not yet recruiting to recruiting.